The Latest ObamaCare Assault On Health Care Innovation

“But when applied from on high by government bureaucrats, CER can yield dangerous results.
A new study from my Pacific Research Institute colleague Dr. Ben Zycher indicates that the government-led CER process will depress investment in pharmaceutical and medical device research and development by 10% to 12% — about $10 billion per year.
Less investment in R&D means fewer revolutionary medical advances that can improve or extend our lives.”